Weave Named Exclusive Patient Engagement Platform Endorsed for American Dental Association Members
Weave to Present at Raymond James 47th Annual Institutional Investors Conference
Weave Earns a Top Spot on G2’s 2026 Best Software Awards for Best Healthcare Software
Weave Communications (NYSE:WEAV) had its price target lowered by analysts at Stifel Nicolaus from $11.00 to $9.00. They now have a "buy" rating on the stock.
Weave Communications (NYSE:WEAV) had its price target lowered by analysts at Piper Sandler from $12.00 to $8.00. They now have an "overweight" rating on the stock.